The apolipoprotein E-⑀4 (APOE-⑀4) allele is associated with poor outcome after head injury and spontaneous intracerebral hemorrhage (SICH). The aims of this study were to determine if patients in whom one or more APOE-⑀4 alleles are present are more likely to sustain intracranial mass lesions after head injury and to determine whether there is an isoform-specific effect on the size of the intracranial hematoma.
HE considerable variability in outcomes after head injury is only partly explained by known prognostic features such as patient age and clinical or investigative indices of injury severity. The results of recent studies suggest that different alleles of the APOE gene are associated with differing outcomes after head injury. 6, 10, 22 Three alleles of the gene (APOE-⑀2, -⑀3, and -⑀4) occur with population frequencies of 0.7, 0.78, and 0.15, respectively. 4 Individuals with one or more APOE-⑀4 alleles are more likely to have poor outcomes after head injury. 22 Apolipoprotein E, the protein coded for by the APOE gene located on chromosome 19, has diverse biological properties that may be linked to outcome after brain injury. Findings of a number of clinical studies support the concept that the APOE genotype not only influences outcome after head injury, but also after ischemic stroke 19 and SICH. 1 In addition, carriers of the APOE-⑀4 allele have been shown to recover neuropsychological and cognitive functions less well following cardiac bypass surgery. 21 A small study of prolonged posttraumatic coma showed that patients with the APOE-⑀4 allele are less likely to recover consciousness than those without an APOE-⑀4 allele. 20 The mechanisms that underlie this genetically determined variation in response to acute brain injury remain to be completely elucidated. The aims of this study were to determine if patients with one or more APOE-⑀4 alleles are more likely to suffer intracranial mass lesions after head injury and whether there is an isoform-specific effect on the size of the intracranial hematoma.
Clinical Material and Methods

Patient Population
Data were available on 1083 patients who had been prospectively enrolled in a study in which the effect of the APOE genotype on outcomes of head injury was investigated at the Institute of Neurological Sciences in Glasgow between September 13, 1995, and July 11, 1999 . The hos- Effect of apolipoprotein E genotype on hematoma volume after trauma pital ethics committee approved the study, and informed consent was obtained from all patients or their relatives before enrollment in the study.
A variety of demographic, injury, and management information was collected using a standardized form and entered into a database, as previously described. 22 Outcome was assessed in a manner blind to genotype, at 6 months after injury by using the GOS. 9 The APOE genotype was determined by subjecting buccal smear samples to polymerase chain reaction and restriction enzyme digestion as previously reported. 25 
Cohort of Patients With Intracranial Hematoma
Information on all patients with intracranial hematomas (extradural, subdural, or contusional) was retrieved using the CT classification field included in the database to identify appropriate study patients. In total, 428 hematomas were identified. Patients were excluded if the time of injury was unknown or if there was no preoperative CT scan available in a digital format suitable for computerized volumetric measurement of the hematoma. The final study cohort consisted of 129 patients with a total of 142 hematomas (Fig. 1) . Intraaxial hematomas were present in 71 patients, extraaxial hematomas in 45 patients, and a combination of intra-and extraaxial lesions in 13 patients.
Volumetric Analysis
Optical disks containing the CT scans of all patients in the hematoma cohort were retrieved from the hospital archives. Areas of high and low density, taken as representative of blood and ischemia/edema, respectively, were analyzed separately in patients with intraparenchymal lesions. These areas together with high-density areas visible in patients with subdural and extraaxial hematomas were analyzed in a manner blind to the APOE genotype by using a computerized image analysis system (Elscint Omnipro [now Marconi MxView; available from Marconi Medical Instruments Inc., Cleveland, OH]). This computer package consists of an independent diagnostic viewing and processing workstation. Using the mouse, the operator can select areas of interest on each CT slice. The program utilizes interactive minimum-and maximum-intensity projection methods to calculate and display two-dimensional projections in a three-dimensional volume of interest and calculate the volume of the three-dimensional object. Figure 2 shows an example of the output produced by the system. The total high-density volume on each patient's scan was used as the dependent variable for the analysis. In individuals in whom both intra-and extraaxial hematomas were identified the volumes of the separate lesions were summed to provide a total high-density volume.
Statistical Analysis
The frequencies of the various alleles (APOE-⑀2, -⑀3, and -⑀4) were compared using chi-square tests for those patients with and those without a hematoma, those patients with an extraaxial and intraaxial hematoma, and those patients with a hematoma who were enrolled and those not enrolled in the study. Measurements of interest comprised genotype APOE-⑀4 (presence or absence of at least one APOE-⑀4 allele), hematoma volume (cube root transformed to meet more adequately the assumption of normality as the response in the linear regressions), patient sex, patient age (Ͻ 35 years, 35 to Ͻ 60 years, or Ն 60 years), injury severity (GCS score on admission of mild [13] [14] [15] , moderate [9] [10] [11] [12] , or severe [3] [4] [5] [6] [7] [8] ), time from injury to first CT scan (Յ 6 hours, Ͼ 6 to 24 hours, or Ͼ 24 hours), hematoma location (intraaxial, extraaxial, or both), injury mechanism (assault, fall, or other, including RTAs-either as occupant or pedestrian), hypoxia (Yes or No), and hypotension (Yes or No). The GOS score determined at 6 months was also recorded, with a poor outcome defined as death or persistent vegetative state (GOS Scores 1 and 2, respectively). All these factors were compared between those patients with and those without APOE-⑀4 allele. Fisher exact tests were used for categorical covariates (patient age and sex; injury mechanism, location, and injury severity; time to first CT scan; hypoxia; hypotension; and GOS score), and Wilcoxon rank-sum tests were performed for continuous covariates (patient age, time to first CT scan, and hematoma volume). Wilcoxon rank-sum tests or twosample t-tests (cube root-transformed hematoma volume) were performed. Simple linear regressions of the cube root-transformed hematoma volume on each factor in turn were fitted. A multiple linear regression model on this response, adjusting for patient age, hours from injury to CT scan, injury severity, injury mechanism, hematoma location, and APOE-⑀4 allele status was fitted. In addition, a separate multiple linear regression model that included factors with missing data (hypoxia and hypotension) was fitted. All analyses were performed using statistical computer software (SAS version 8.2 for Windows NT; SAS Institute, Cary, NC). No adjustment has been made for multiple comparisons.
Results
Allele Frequencies
The allele frequencies for the various patient cohorts are shown in Table 1 . There were no significant differences between groups with regard to allele frequency, indicating that possession of an APOE-⑀4 allele does not make an individual more or less likely to sustain an intracranial hematoma after head injury (p = 0.36). The allele frequencies associated with the presence of extraaxial and intraaxial lesions are similar, indicating that the APOE genotype is unlikely to influence differentially the likelihood of sustaining an extraaxial or intraaxial hematoma (p = 0.98). The allele frequencies in the cohort selected for volumetric analysis are no different from those of patients excluded for the reasons outlined in Clinical Material and Methods, showing that patient selection did not introduce bias for this variable (p = 0.83).
Demographic and Injury Details
Demographic, injury, and management details of the patients are shown in Table 2 . There were no significant differences between patients with an APOE-⑀4 allele and those without this allele in age (p = 0.19), sex (p = 1.00), mechanism of injury (p = 0.052), injury severity (p = 0.071), time from injury to CT scan (p = 0.62), intra-or extraaxial hematoma (p = 0.69 and p = 0.12, respectively), hypoxia (p = 0.83), or hypotension (p = 0.74). Falls were a common mechanism of injury in this patient group. This is partly due to the selection of patients with hematomas from the overall study population. Hematomas are known to occur more frequently as a result of falls. 8 In the overall group of 1083 patients with head injury admitted to the neurosurgical unit, 22.2% of injuries were the result of RTAs, 21% the result of assaults, and 49.8% the result of falls. This is a fairly representative sample of the pattern of injuries seen in western Scotland.
The results of the univariate analysis confirmed a worse GOS score (death or persistent vegetative state) at 6 months in those patients with an APOE-⑀4 allele (43% with poor outcomes) compared with those without the allele (21% with poor outcomes) (p = 0.015).
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FIG. 2. A:
A CT scan revealing extradural and subdural hematomas and an intracerebral contusion. B and C: The three-dimensional objects generated by the computer can be observed within the cranial vault (B) and with the bone removed (C). 
Analysis of Hematoma Volumes
Results of the univariate analysis revealed that in patients with one or more APOE-⑀4 alleles the median hematoma volume was significantly higher than that in patients without the allele (35.2 cm 3 compared with 13.6 cm 3 , p = 0.0056) (Fig. 3 and Table 2 ). Similarly, the cube root-transformed volume showed a significant difference in means (3.1 cm compared with 2.5 cm, p = 0.0039). Table 3 shows the differences in mean cube root-transformed hematoma volumes for the various factors first alone and then after adjustment for the other factors. There were significant effects of patient age (p = 0.038), hematoma location (p Ͻ 0.0001), and injury severity (p = 0.014). Time to CT scan, hypoxia, and hypotension did not significantly affect the cube root-transformed hematoma volume.
After adjusting for all these factors simultaneously (except hypoxia and hypotension, which were omitted due to missing values [similar results were found in a separate model when these factors were included]), in a multiple linear regression model presence of one of more APOE-⑀4 alleles, patient age, hematoma location, and injury severity emerged as independent predictors (significant at p Ͻ 0.05) of the cube root-transformed hematoma volume.
Discussion
Allele frequencies did not differ between patients with and those without intracranial hematomas, suggesting that the APOE genotype does not affect the risk of suffering an intracranial hematoma after head injury. The presence of an APOE-⑀4 allele, however, does predict a larger hematoma, both univariately and after adjusting for patient age, hours since the CT scan, injury severity, injury mechanism, and hematoma location. ‡ "Other" includes RTA in which the patient was a vehicle occupant (seven patients), RTA in which the patient was a pedestrian (18 patients), and sport (one patient).
§ Data were missing in some patients.
It is unlikely that differences in hematoma volume are a consequence of differences in other factors between the two groups. The effects of other factors that were thought to influence hematoma size, such as patient age, time from injury to CT scan, injury severity, and hematoma location, have been controlled for as main effects in the multiple linear regression analysis. Further analyses in which pairwise interactions between these factors were sought did not find any such interactions significant at a probability level lower than 0.01, but the present study probably does not have sufficient power to detect such interactions of interest reliably if, in fact, they existed. Larger studies would be needed to tease out the complexities of interrelationships between these factors with respect to hematoma volume and APOE-⑀4 allele status.
An initially counterintuitive observation that patients with less severe injuries tended to have larger hematomas is likely to be explained by the fact that patients with milder injuries were more likely to have extraaxial hematomas and to have sustained their injuries as the result of a fall rather than an RTA or other mechanism. Both these factors might contribute to less severe primary brain injury in these patients. Nevertheless, none of these differences reached statistical significance and the difference in hematoma volume between patients with and those without the APOE-⑀4 allele persists when adjustment is made for these factors in the multivariate model.
The measurement of hematoma volume is subjective to the extent that the operator identifies the area of hemorrhage on each CT slice. All volume measurements were performed in a manner blind to genotypes, however, and this should not be a source of bias in the study. Two hundred ninety-nine patients with hematomas were excluded from the study because there was either no preoperative CT scan available or the time of injury was not accurately known. These patients did not differ in terms of allele frequency, patient age, or mechanism or severity of injury, compared with the patients under investigation. The results from the study cohort should, therefore, have general applicability.
Intracranial hematomas are known to occur more commonly after head injury in patients who have sustained injuries as a result of falls, in more elderly patients, and in patients with disorders of coagulation. 8 To our knowledge this is the first study in which a genetic influence on hematoma size after head injury has been identified.
McCarron and colleagues 14 assessed hematoma volume in patients with SICH and did not find any difference in patients with APOE-⑀4 alleles. This may reflect a pathologically specific isoform effect, although it is noteworthy that the CT scans in their study were all obtained within 24 hours of ictus and later scans might have uncovered a difference. More recent data 24 indicate that patients with APOE-⑀4 alleles may have subtle coagulation abnormalities, and this theory has been proposed as a possible mechanism for both the improved survival of patients with ischemic stroke and the poorer outcomes in patients with SICH who possess an APOE-⑀4 allele. 13 Isoform-specific differences in blood coagulation could explain the findings in the current study. The APOE-⑀4 allele has been reported to be associated with decreased vitamin K levels. 18 Prothrombin times have also been reported to vary with the APOE genotype in patients suffering from alcoholism-induced cirrhosis. 7 In other studies an increased likelihood of recurrent cerebral amyloid angiopathy-related hemorrhage 16 and atherosclerosis 17 has been identified in patients with the APOE-⑀4 allele. Such pathological vascular conditions in brains of persons harboring the APOE-⑀4 allele may render intracranial vessels more susceptible to rupture following the contact or shear strains that occur after a head injury, providing a further possible explanation for the larger hematomas. Such degenerative vascular processes, however, tend to be most prominent in elderly patients and, on average, victims of head injury are younger.
The APOE-⑀4 allele is associated with increased levels of intracellular calcium, 23 decreased antioxidant activity, 15 decreased immunosuppressive effect on microglial proliferation, 2 and of tumor necrosis factor-␣ production. 11 Findings of such studies indicate that there may be a larger inflammatory response in patients with the APOE-⑀4 allele after head injury. This may result in a greater degree of lipid peroxidation, increased capillary permeability, erythrocyte diapedesis, and perivascular blood accumulation. Authors of several studies have implicated these processes in the formation of intracerebral hematomas. 3, 12 The APOE-⑀4 allele is associated with poor cytoskeletal synthesis as well as with diminished synaptogenesis and neurite growth. 15 This may render neurons in carriers of the APOE-⑀4 allele more susceptible to traumatic mechanical distortion and subsequent ionic fluxes. Together with the previously mentioned isoform-specific APOE immunomodulatory activity, this may cause greater cytotoxic edema and increase intraaxial hematoma volume. The results of a recent study have indicated that brains of twins harboring APOE-⑀4 alleles are significantly smaller than siblings without this allele. 5 Increased atrophy in brains carrying the APOE-⑀4 allele may predispose to larger hematomas.
One or more of the aforementioned mechanisms may explain the larger hematoma volumes observed in patients with the APOE-⑀4 allele, and different mechanisms may be involved in different types of hematoma (for example, intraaxial as opposed to extraaxial hematomas; Fig. 4 ). The larger hematomas may also be partially responsible for the worse outcome that this group of patients is known to experience after injury. Nevertheless, McCarron, et al., 14 failed to find evidence of larger hematoma volumes in their study of SICH but did confirm worse outcomes in patients with the APOE-⑀4 allele indicating that the APOE-⑀4 allele may also influence outcome by other mechanisms.
Conclusions
In our series of 1083 head-injured patients, analysis of allele frequencies showed that the APOE genotype does not influence the likelihood of suffering a mass lesion after traumatic brain injury. Linear regression analyses demonstrate that the presence of an APOE-⑀4 allele is an independent predictor of a larger intracranial hematoma after head injury, compared with the presence of its isoforms. 98 referent * The adjusted differences are based on a multiple linear regression of cube root-transformed hematoma volume on patient age, hours since CT scan, injury severity, injury mechanism, location of hematoma, and APOE-⑀4 allele status for 129 patients. Abbreviation: CI = confidence interval.
† Hypoxia and hypotension were not included in the reported multiple linear regression model due to missing values (19 for hypoxia and 18 for hypotension), but similar results were obtained from a separate model with 110 patients that included these two factors.
The larger hematomas found in patients with the APOE-⑀4 allele may partly explain the poorer outcomes after head injury observed in these patients.
